South Korea Faces 15 Percent Pharma Tariffs Under Trump Section 232 Rule Starting July 2026
·3 min
This segment discusses the imposition of 15% tariffs on South Korean pharmaceutical imports under U.S. Section 232 rules starting July 2026, as part of broader trade measures aimed at reducing deficits and securing supply chains.
